title: [Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
authors.affiliation: Hospital Universitari Germans Trías i Pujol, Badalona, Barcelona, Spain. domenech@ns.hugtip.scs.es
authors.forename: E
authors.initials: E
authors.lastname: Domènech
authors.forename: M
authors.initials: M
authors.lastname: Esteve-Comas
authors.forename: F
authors.initials: F
authors.lastname: Gomollón
authors.forename: J
authors.initials: J
authors.lastname: Hinojosa
authors.forename: A
authors.initials: A
authors.lastname: Obrador
authors.forename: J
authors.initials: J
authors.lastname: Panés
authors.forename: M A
authors.initials: MA
authors.lastname: Gassull
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000075202:Contraindications; D003424:Crohn Disease / Q000188:drug therapy* / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab